Company Active PRIVATE-LIMITED-GUARANT-NSC

Company profile

Imperial College Health Partners Limited

Home - Imperial College Health Partners

Imperial College Health Partners Limited is a UK company with status active founded in 2012 based in London.

CRN
08109403
Founded
2012
Age
14

Overview

Legal name
IMPERIAL COLLEGE HEALTH PARTNERS LIMITED
Region
London
Registered address
C/O MILLS & REEVE LLP
24 KING WILLIAM STREET
LONDON
ENGLAND
EC4R 9AT
Insolvency history
No

Company events

Reference milestones and recent Companies House filing stream events.

11 events
31 Dec
2026

Accounts due

Accounts Due

Next accounts due date

21 Jun
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

10 Apr
2026

Appoint Person Director Company With Name Date

Officers

AP01 | Transaction MzUxNTM3NDAxM2FkaXF6a2N4

Published 10 Apr 2026 12:05

07 Jun
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Mar
2025

Accounts filed

Accounts

Last accounts made up date

28 Oct
2024

Termination Secretary Company With Name Termination Date

Officers

TM02 | Transaction MzQ0MTEyNTM4MmFkaXF6a2N4

Published 28 Oct 2024 02:27

21 Oct
2024

Appoint Person Director Company With Name Date

Officers

AP01 | Transaction MzQ0MDI3MTIxOWFkaXF6a2N4

Published 21 Oct 2024 09:17

13 Aug
2024

Memorandum Articles

Incorporation

MA | Transaction MzQzMTk5NzE1MmFkaXF6a2N4 | Paper/PDF filed

Published 14 Aug 2024 07:58

13 Aug
2024

Resolution

Resolution

RESOLUTIONS | Transaction QUQ5NTVIVFNhZGlxemtjeA | Paper/PDF filed

Published 14 Aug 2024 07:58

13 Aug
2024

Resolution

Resolution

RESOLUTIONS | Transaction QUQ5NTVIVENhZGlxemtjeA | Paper/PDF filed

Published 14 Aug 2024 07:58

18 Jun
2012

Incorporated

Inception

Company registered at Companies House

Public funding

2 awards
First funded
2017
Funded years
2017, 2018
Age at first award
4 years

Projects

2018 Collaborative R&D

Developing a Schedule for Unscheduled Care

1 Oct 2018 to 30 Sep 2020

Awarded
£219,663
Total cost £219,663

"The NHS is a complex system, we have expert staff across all elements of our services, but it can be confusing for patients to know where best to go. Our offering to patients is old fashioned, we have only two streams; unscheduled and scheduled; life isn't quite like that, sometimes you need something in between. As an NHS organisation working with innov...

2017 Collaborative R&D

Comprehensive blood counts in a handheld device: home monitoring in chemotherapy

1 Mar 2017 to 31 Mar 2019

Awarded
£23,199
Total cost £33,141

For many individuals with cancer, chemotherapy forms a key aspect of treatment. Across the various types of chemotherapy, the majority carry significant side effects that often include the reduction of blood cell counts. The lowering of blood cell counts exposes individuals to higher risk of adverse events such as infection. Low blood counts are also the ...

Product types

Collaborative R&D